Medwell Capital
3
5M
2
1
0.33
1
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the Edmonton. The venture was found in North America in Canada.
Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this Medwell Capital works on 4 percentage points more the average amount of lead investments. The top activity for fund was in 2011. The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is generally included in less than 2 deals every year.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Medwell Capital, startups are often financed by iNovia Capital, VIMAC Milestone Medical Fund, MSBi Valorisation. The meaningful sponsors for the fund in investment in the same round are Toray Industries, Schooner Capital. In the next rounds fund is usually obtained by Schooner Capital.
Among the various public portfolio startups of the fund, we may underline Mimetogen Pharmaceuticals Among the most popular fund investment industries, there are Clinical Trials, Therapeutics. For fund there is a match between the location of its establishment and the land of its numerous investments - Canada. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Exits
- 1
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Medical (2)
- Clinical Trials (2)
- Pharmaceutical (2)
- Health Diagnostics (1) Show 2 more
- Investments by region
-
- Canada (3)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 24
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Mimetogen Pharmaceuticals | 25 Feb 2011 | Biotechnology, Medical, Pharmaceutical, Clinical Trials | Early Stage Venture | 2M | Canada, Quebec, Montreal |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.